The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: Insights from ASSENT-2

European Heart Journal

Volumn 24, Issue 11, 2003, Pages 1024-1034

  Tjandrawidjaja, Michael C ^a   Fu, Yuling ^a   Goodman, Shaun G ^b   Van de Werf, Frans ^c   Granger, Christopher B ^d   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Fibrinolysis; Gender; Myocardial infarction; Reinfarction; Revascularization; Trials

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CORONARY STENT; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYSIS; GENDER; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; DRUG COMBINATIONS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RECURRENCE; SEX FACTORS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0038202918     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00082-4     Document Type: Article

References (28)

1. Krumholz HM, Murillo JE, Chen J et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 1997;277:1683-8.
2. Barron HV, Bowlby LJ, Breen T et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-6.
3. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med 1991;325:221-5.
4. Maynard C, Litwin PE, Martin JS et al. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992;152:972-6.
5. Funk M, Griffey KA. Relation of gender to the use of cardiac procedures in acute myocardial infarction. Am J Cardiol 1994;74:1170-3.
6. Kostis JB, Wilson AC, O'Dowd K et al. Sex differences in the management and long-term outcome of acute myocardial infarction. A statewide study. MIDAS study group. Myocardial Infarction Data Acquisition System. Circulation 1994;90:1715-30.
7. Krumholz HM, Douglas PS, Lauer MS et al. Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med 1992;116:785-90.
8. Lincoff AM, Califf RM, Ellis SG et al. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? J Am Coll Cardiol 1993;22:1780-7.
9. Behar S, Gottlieb S, Hod H et al. Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. The Israeli Thrombolytic Survey Group. Am J Cardiol 1994;73:438-43.
10. White HD, Barbash GI, Modan M et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. Circulation 1993;88:2097-103.
11. Vaccarino V, Krumholz HM, Berkman LF et al. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation 1995;91:1861-71.
12. Weaver WD, White HD, Wilcox RG et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. JAMA 1996;275:777-82.
13. Moen EK, Asher CR, Miller DP et al. Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. J Women's Health 1997;6:285-93.
14. Woodfield SL, Lundergan CF, Reiner JS et al. Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol 1997;29:35-42.
15. Vaccarino V, Parsons L, Every NR et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999;341:217-25.
16. The GUSTO-V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomized trial. Lancet 2001;357:1905-14.
17. The ASSENT-3 (Assessment of the Safety and Efficacy of a New Thrombolytic Regimen) Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction. Lancet 2001;358:605-13.
18. The HERO-2 (Hirulog and Early Reperfusion or Occlusion Trial) Investigators. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomized trial. Lancet 2001;358:1855-63.
19. Barbash GI, Birnbaum Y, Bogaerts K et al. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO I) and assessment of the safety and of a new thrombolytic (ASSENT-2) studies. Circulation 2001;103:954-60.
20. Hudson MP, Granger CB, Topol EJ et al. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. Circulation 2001;104:1229-35.
21. The ASSENT-2 (Assessment of the Safety and Efficacy of a New Thrombolytic) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet 1999;354:716-22.
22. Aldrich HR, Wagner NB, Boswick J et al. Use of Initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts. Am J Cardiol 1988;61:749-53.
23. Willems JL, Willems RJ, Willems GM et al. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. Circulation 1990;82:1147-58.
24. Schuster EH, Bulkley BH. Early post-infarction angina: ischemia at a distance and ischemia in the infarct zone. N Engl J Med 1981;305:1101-5.
25. Bosch X, Theroux P, Waters DD et al. Early post-infarction ischemia: clinical, angiographic, and prognostic significance. Circulation 1987;75:988-95.
26. Ohman EM, Califf RM, Topol EJ et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990;82:781-91.
27. Betriu A, Califf RM, Bosch X et al. Recurrent ischemia after thrombolysis: Importance of associated clinical findings. J Am Coll Cardiol 1998;31:94-102.
28. Lee KL, Woodlief LH, Topol EJ et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.